Fundraising FoxaMoon — 2020 Investments
6 investments dated 2020 · listed companies and verified rows first · show all
Viracta Therapeutics was a precision oncology company.
BiotechHealthtechCardiff, US
James Woody(Director)David Slack(Executive Officer)
BoardIvor Royston(Executive Officer, Director)Patrick Soon-Shiong(Director)Richard Ghalie(Director)
Board seatGur Roshwalb· per SEC Form D · $40M raise · filed Dec 2020
Co-investorsAisling CapitalLatterell Venture PartnersVirtus Inspire Ventures
Curesponse applies science and technology to improve cancer treatment, bringing together medical executives, scientists, and clinical and regulatory experts.
AI & Machine LearningBiotechDigital HealthHealthtech
Guy Neev(Co-Founder & CEO)inDr. Ravid Straussman(Scientific Founder)Dr. Seth Salpeter(Co-Founder & CTO)Eran Dor(CFO)
Co-investorsNCL Technology Ventures Ltd.
MOBILion Systems develops the MOBIE platform, a high-resolution ion mobility mass spectrometry (HRIM-MS) instrument that separates and identifies complex molecules in separation science.
BiotechDeep TechHardwareExton, US
MELISSA SHERMAN(Executive Officer, Director)in
BoardJASON SMITH(Director)inMICHAEL ALBIN(Director)JUDIT LOSONCZI(Director)HEINER DREISMANN(Director)
Co-investorsAnzu PartnersArgonautic VenturesiSelect FundCultivation Capital
PrognomiQ is a clinical-stage company developing blood-based tests for early detection and treatment of cancer and other complex diseases using multi-omics data.
AI & Machine LearningBiotechHealthtechSan Mateo, US
Philip Ma, Ph.D.(Executive Officer, Director)Philip Ma(Chief Executive Officer & Founder)inOmid Farokhzad(Chair of the Board of Directors)inDavid Siewers(Chief Financial Officer)inBrian Koh(Chief Medical Officer)inBruce Wilcox(Chief Technology Officer)in
Co-investorsCatalio Capital Management, LPWingMaverick Ventures
SOPHiA GENETICS develops the SOPHiA DDM data analytics platform for genomic and multimodal data analysis, offering solutions used in oncology research and in vitro diagnostics.
AI & Machine LearningBiotechDigital HealthMedical Devices
Jurgi Camblong(Founder)Lars Steinmetz(Founder)Pierre Hutter(Founder)
Co-investors360 CapitalBalderton CapitalCompoundHitachi VenturesACE & CompanyAlychlo+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
MiNA Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.